Literature DB >> 3556306

Slow moving proteinase. Isolation, characterization, and immunohistochemical localization in gastric mucosa.

I M Samloff, R T Taggart, T Shiraishi, T Branch, W A Reid, R Heath, R W Lewis, M J Valler, J Kay.   

Abstract

Human gastric mucosa contains three immunochemically distinguishable aspartic proteinases, pepsinogen I (pepsinogen A), pepsinogen II (pepsinogen C, progastricsin), and a nonpepsinogen proteinase also termed slow moving proteinase (SMP). The properties of SMP, and in particular its relationship to another aspartic proteinase, cathepsin D, were examined in this study. Slow moving proteinase and cathepsin D were isolated, respectively, from gastric mucosa and human spleen. Antiserum specific to each proteinase was prepared in rabbits. Rabbit anti-SMP did not recognize cathepsin D, and conversely, anticathepsin D did not react with SMP. Immunohistochemical studies localized SMP to surface epithelial cells in both the fundic and pyloric gland areas of the stomach. In contrast, cathepsin D was found mainly in mononuclear cells in the lamina propria and in parietal cells. Slow moving proteinase exhibited considerably lower Km values for its interaction with two chromogenic substrates than did cathepsin D. An even greater distinction between the two enzymes was found with the protein inhibitor from Ascaris lumbricoides; the activity of SMP was inhibited very strongly, whereas that of cathepsin D was not affected. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis under denaturing conditions, SMP consisted of two subunits with apparent molecular weights of 42,500 and 41,000. The last two properties characterize a less-well-known aspartic proteinase, cathepsin E. We conclude that SMP is not cathepsin D, but that it may be cathepsin E.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556306

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Substrate and inhibitor studies with human gastric aspartic proteinases.

Authors:  A Baxter; C J Campbell; C J Grinham; R M Keane; B C Lawton; J E Pendlebury
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

2.  Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study.

Authors:  T Saku; H Sakai; N Tsuda; H Okabe; Y Kato; K Yamamoto
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

3.  Biochemical characterization and structural modeling of human cathepsin E variant 2 in comparison to the wild-type protein.

Authors:  Vida Puizdar; Tajana Zajc; Eva Zerovnik; Miha Renko; Ursula Pieper; Narayanan Eswar; Andrej Sali; Iztok Dolenc; Vito Turk
Journal:  Biol Chem       Date:  2012-03       Impact factor: 3.915

4.  Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E.

Authors:  R A Jupp; A D Richards; J Kay; B M Dunn; J B Wyckoff; I M Samloff; K Yamamoto
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  Slow moving proteinase in gastric cancer and its relationship to pepsinogens I and II. An immunohistochemical study.

Authors:  T Shiraishi; I M Samloff; R T Taggart; G N Stemmermann
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

6.  Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing.

Authors:  G Finzi; M Cornaggia; C Capella; R Fiocca; F Bosi; E Solcia; I M Samloff
Journal:  Histochemistry       Date:  1993-03

7.  Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteases.

Authors:  Rebecca E Moose; José C Clemente; Larry R Jackson; Minh Ngo; Kimberly Wooten; Richard Chang; Antonette Bennett; Sibani Chakraborty; Charles A Yowell; John B Dame; Mavis Agbandje-McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

8.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Coexpression of aspartic proteinases and human leukocyte antigen-DR in human transplanted lung.

Authors:  E Arbustini; P Morbini; M Diegoli; M Grasso; R Fasani; P Vitulo; R Fiocca; P Cremaschi; G Volpato; L Martinelli
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Pepsin concentration in gastroduodenal biopsy homogenates in chronic ulcer disease.

Authors:  F Vianello; F Di Mario; M Plebani; B Germana; P Dal Santo; G Leandro; P Dotto; S A Grassi; G Battaglia; R Naccarato
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.